Trial Profile
Phase I/II: Umbilical Cord Derived Mesenchymal Stem Cells Transplantation For Active And Refractory Systemic Lupus Erythematosus
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Jan 2023
Price :
$35
*
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy-Beike (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions
- Sponsors Beike Biotechnology
- 22 May 2014 New trial record
- 25 Mar 2014 Results published in Arthritis Research and Therapy.